Immunotherapy is the use of medicines that help a person’s own immune system find and destroy cancer cells. It can be used to treat some people with liver cancer. An important part of the immune ...

A novel liver-on-a-chip model can be used to study immune cell interactions in liver cancer and test promising new therapies.

aDepartment of Hematology/Oncology, Comprehensive Cancer Center (CCC Munich), LMU University Hospital Munich, 81377 Munich, Germany bDepartment of Hematology, Oncology, and Cancer Immunology (CCM), ...

Hepatocellular carcinoma or HCC is the most commonly observed form of liver cancer and the fourth leading cause of ...

A new report says that 13 percent of cancers are linked to bacteria or viruses. Vaccines and treatments offer powerful ...

A team led by Sylvain Meloche, Professor in the Faculty of Medicine at UdeM and Director of IRIC's Signaling and Cell Growth ...

Liver cancer, or hepatic cancer, is a malignant tumour that grows on the surface or inside the liver. The leading cause is a viral infection with hepatitis B or C virus. The most frequent liver ...

A study in JAMA Network Open reveals a rise in drug-induced liver injuries associated with herbal supplements like green tea ...

“ Fatty liver (steatosis) occurs when fat accumulates around the liver cells, and the process of breaking down fat slows down ...

Merck and Daiichi Sankyo's HER3 antibody-drug conjugate reported a positive phase 3 result in EGFR-mutated lung cancer. Merck ...

A new prognostic model can predict and stratify hepatocellular carcinoma (HCC) risk in noncirrhotic adult patients with chronic hepatitis B (CHB), according to a study published online Sept.